Order Monovisc® for Clinics

Monovisc® is a sterile, single-dose hyaluronic acid viscosupplement supplied in a 4 mL prefilled syringe for intra-articular administration. Licensed clinics and healthcare professionals can order Monovisc® for knee osteoarthritis workflows that use a one-visit injection protocol. The monovisc 88 mg 4 ml presentation supports treatment-room setup, lot-level documentation, and standardized procedural scheduling.

Med Wholesale Supplies serves professional buyers with brand-name medical products sourced through vetted distributors and verified supply channels. Monovisc® is intended for administration by trained healthcare professionals using aseptic technique and facility-approved procedures.

Monovisc® Price, Ordering, and Clinic Account Access

Clinics can sign in to view current Monovisc® price information tied to their account profile. The displayed cost may depend on contracted terms, volume, purchasing history, and the exact quantity selected during checkout. For purchase requests, use the full product name and syringe details so procurement staff can match the item to the intended knee intra-articular protocol.

When evaluating monovisc cost per injection, include more than the syringe acquisition cost. Many facilities also account for procedure-room time, sterile prep supplies, staff documentation, ultrasound guidance when used, and follow-up workflow. The single-injection format may simplify scheduling compared with multi-visit viscosupplement series, but clinical selection should remain protocol-driven.

Quick tip: Keep the lot number, expiration date, and procedure note together in your inventory and clinical documentation workflow.

What Monovisc® Is Used For in Professional Practice

Monovisc® is a high molecular weight hyaluronan product used as a viscosupplement for osteoarthritis-related knee pain in appropriate patients. Viscosupplementation is designed to supplement synovial fluid, the lubricating fluid inside a joint. After intra-articular placement, the viscoelastic solution may support joint lubrication and load distribution as part of a broader conservative-care pathway.

Orthopedic and rheumatology teams may incorporate the monovisc 4ml injection after clinical evaluation, review of prior conservative measures, and assessment of procedural suitability. Candidate selection, timing, local anesthesia, imaging support, and follow-up intervals should follow the clinician’s judgment, product instructions, and current clinic policy.

For broader category planning, clinics can browse orthopedic injections and rheumatology products alongside their musculoskeletal procedure inventory. These category groupings can help teams align intake forms, consent language, sterile supplies, and aftercare instructions across related services.

Strength, Syringe Format, and Composition

This presentation corresponds to monovisc 88 mg 4 ml in one sterile, ready-to-use syringe. The active component is sodium hyaluronate, a form of hyaluronic acid, in an isotonic sterile solution suitable for intra-articular use. The syringe is single-use and should be discarded according to facility policy after the procedure.

The monovisc syringe reduces preparation variability because staff do not need to draw the product from a vial or assemble a multi-dose sequence. The format also supports predictable procedure-room setup, standard labeling review, and straightforward capture of lot and expiry data. Do not mix the contents with other injected products unless the manufacturer’s instructions specifically support that practice.

How the Single-Injection Workflow Fits Clinic Operations

Monovisc® is often selected when a clinic wants a one-visit viscosupplement option rather than a multi-injection series. A typical workflow includes evaluation, consent, sterile skin preparation, joint access, injection, post-procedure observation as needed, and documentation. Some practices use ultrasound guidance based on provider preference, anatomy, prior procedure history, or internal policy.

The single-injection format can reduce rebooking burden and simplify tracking because one procedural entry can capture the product, lot, site, approach, and aftercare instructions. It may also help high-volume orthopedic clinics allocate procedure blocks more predictably. For a focused discussion of the format, see the single-injection Monovisc® workflow.

Many teams pair viscosupplement inventory with procedure carts that include gloves, antiseptic, sterile drapes, needles, syringes used for local anesthetic when applicable, sharps containers, and clinic-specific aftercare handouts. Standard kits can reduce variation between providers while preserving clinical discretion.

Handling, Storage, and Supply Documentation

Keep Monovisc® in its original packaging until the procedure team is ready to prepare the treatment area. Follow the manufacturer’s insert for storage conditions, inspection before use, sterility checks, and any handling limits. Do not use a syringe if the package is damaged, the sterility barrier is compromised, or the expiration date has passed.

Ordering teams should record product name, strength, quantity, lot number, expiration date, and receiving date in the facility’s inventory system. Temperature-controlled handling when required and tracked US delivery can support receiving controls, but the clinic remains responsible for accepting shipments promptly and storing medical products according to the label.

SKU: 82463. Include the SKU and monovisc 88 mg 4 ml syringe description on purchase orders to reduce substitution risk. If your facility permits substitutions, require clinical review before switching to a different hyaluronic acid system because injection schedules, molecular characteristics, packaging, and device handling can differ.

Safety, Contraindications, and Monitoring

Monovisc® must be administered into the joint space by a qualified healthcare professional. The manufacturer’s instructions should guide patient screening, aseptic technique, contraindications, and post-injection precautions. Do not administer the product into infected or inflamed skin, and avoid use when the joint is actively infected or when patient-specific contraindications apply.

Potential adverse effects associated with intra-articular hyaluronic acid products can include injection-site pain, swelling, warmth, stiffness, bruising, or temporary joint discomfort. Less common but clinically important concerns include hypersensitivity reactions, significant inflammatory reactions, bleeding complications in susceptible patients, or infection. Clinics should have a process for escalation if a patient develops severe pain, fever, marked swelling, rash, or other unexpected symptoms after the procedure.

Medication and medical-history review remains important even though Monovisc® is locally administered. Anticoagulant use, immune status, prior reactions to viscosupplements, skin conditions near the injection site, and planned joint procedures may affect timing or monitoring. Clinicians should document the risk-benefit discussion and provide aftercare instructions consistent with facility policy.

Expected Clinical Timeline and Patient Counseling Points

Search interest often focuses on how long Monovisc® injections last, but duration can vary by patient, joint condition, activity level, and clinical history. Manufacturer and clinical materials describe Monovisc® as a single-injection viscosupplement used for osteoarthritis knee pain, but no clinic should promise a fixed response time or guaranteed duration. Counsel patients that symptom changes may not be immediate and that worsening pain or signs of infection require prompt clinical contact.

Procedure teams commonly advise patients to follow clinic-specific activity instructions after injection. Those instructions may include limiting strenuous activity for a short period, monitoring for swelling, and using approved comfort measures if advised by the clinician. Avoid replacing individualized counseling with generic handouts; documentation should reflect the provider’s specific recommendations.

For class-level education that helps staff explain gel injections consistently, see gel injections for knee pain programs. That type of internal training support can help non-prescribing staff understand terminology without making treatment decisions.

Comparable Hyaluronic Acid Options

Clinics may compare Monovisc® with other hyaluronic acid systems based on injection frequency, device handling, supply availability, patient selection criteria, and formulary policy. Selection is not only a price decision; procedure scheduling, documentation burden, provider familiarity, and aftercare consistency all matter in a busy musculoskeletal service.

For product-level alternatives, facilities may review Hymovis prefilled syringes or Hyalgan syringe inventory when building a broader viscosupplement formulary. Differences in regimen and presentation should be assessed against your clinical protocol before substitution.

For decision support across the class, the Monovisc® and Synvisc comparison explains key similarities and differences, while the Hyalgan comparison may help teams review multi-product planning. Clinics interested in adjacent osteoarthritis injection discussions may also find the Durolane injection article useful for internal education.

Brand and Formulary Planning

Monovisc® is a branded hyaluronic acid product associated with Anika. Facilities that standardize formularies by brand can use the Monovisc® brand collection for related purchasing organization. Brand-level grouping can help procurement teams reduce naming variation across purchase requests and internal preference cards.

Questions about monovisc generic or generic monovisc should be handled carefully. Hyaluronic acid viscosupplements are medical products with specific labeling, device presentations, and clinical-use instructions; one brand should not be treated as automatically interchangeable with another without formal clinical review. If a lower-cost substitute is considered, confirm the product, route, regimen, and procedural impact before changing inventory.

Authoritative Sources

• Manufacturer professional information for MONOVISC®
• FDA Monovisc® information for prescribers
• MedlinePlus hyaluronic acid injection information

Ready to add this single-injection option to your clinic inventory? Sign in to view account-specific terms, select the required quantity, and align receiving with your procedure schedule.

This content is for informational purposes only and is not a substitute for professional medical advice.